Advertisement
Screener

CytomX Therapeutics, Inc. (CTMX) Cash Flow Breakdown

CytomX Therapeutics, Inc. Cash Flow Breakdown

Cash flow breakdown shows where CytomX Therapeutics, Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $75.59M went out.
  • Fiscal year ended 2025-12-31: from investing, $59.74M went out.
  • Fiscal year ended 2025-12-31: from financing, $110.45M came in.
  • Fiscal year ended 2025-12-31: change in cash, $24.89M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew shares soldNot split outChange in cash
2025-12-31-$75.59M-$59.74M$109.64M$811.00K*-$24.89M
2024-12-31-$86.23M$99.70M$6.91M$613.00K*$20.99M
2023-12-31-$56.03M-$150.67M$30.23M*-$176.48M
2022-12-31-$110.79M$98.26M$0.00$648.00K*-$11.88M
2021-12-31-$119.03M$22.49M$107.71M$2.50M*$13.67M
2020-12-31$5.26M-$18.72M$11.29M$5.61M*$3.43M
2019-12-31-$140.48M$79.70M$0.00$1.63M*-$59.15M
2018-12-31-$75.52M$5.93M$134.60M$5.03M*$70.03M
2017-12-31$170.37M-$121.27M$19.96M$3.84M*$72.90M
2016-12-31-$2.03M$45.86M$996.00K*$44.82M
2015-12-31-$27.41M-$130.56M$263.00K$153.14M*-$4.57M
2014-12-31$31.80M-$1.66M$8.00K$25.55M*$55.69M
2013-12-31-$8.01M-$732.00K$62.00K$2.63M*-$6.04M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew shares soldNot split outChange in cash
2026-06-30-$18.07M*$5.95M*$56.00K*
2026-03-31-$25.55M-$192.78M$228.35M$6.14M*$16.16M
2025-12-31-$23.24M*-$14.42M*$16.26M*
2025-09-30-$15.55M*$439.00K*$0.00*
2025-06-30-$15.75M*-$76.36M*$93.37M*
2025-03-31-$21.04M$30.60M$0.00$9.55M
2024-12-31-$19.91M*$15.13M*$2.07M*
2024-09-30-$20.73M*$18.17M*$0.00*
2024-06-30-$19.55M*$21.51M*$5.10M*
2024-03-31-$26.05M$44.88M$19.01M
2023-12-31-$21.96M*$12.87M*
2023-09-30-$18.24M*-$42.94M*$0.00*$29.67M*
2023-06-30-$25.18M*$26.04M*
2023-03-31$9.35M-$146.64M$0.00-$137.29M
2022-12-31-$1.39M*$99.82M*$0.00*
2022-09-30-$33.84M*-$410.00K*$0.00*
2022-06-30-$34.24M*-$412.00K*$0.00*
2022-03-31-$41.31M-$736.00K$7.00K-$42.04M
2021-12-31-$31.19M*-$245.00K*$0.00*$683.00K*
2021-09-30-$29.70M*$9.73M*$0.00*
2021-06-30-$28.20M*-$46.01M*$0.00*$691.00K*
2021-03-31-$29.94M$59.01M$107.71M$1.02M*$137.81M
2020-12-31-$17.43M*$19.45M*$11.29M*$1.73M*
2020-09-30-$24.68M*-$90.07M*
2020-06-30$97.10M*$49.45M*$1.55M*
2020-03-31-$49.74M$2.44M$2.16M-$45.14M
2019-12-31-$29.48M*$52.86M*
2019-09-30-$23.32M*$38.51M*
2019-06-30-$48.65M*$6.94M*$698.00K*
2019-03-31-$39.03M-$18.61M$465.00K-$57.17M
2018-12-31-$28.74M*$15.84M*$0.00*$724.00K*
2018-09-30-$5.55M*-$3.18M*$135.58M*
2018-06-30-$26.62M*$16.65M*$722.00K*
2018-03-31-$14.61M-$23.38M$2.60M-$35.39M
2017-12-31$22.00M*-$149.76M*$21.08M*-$106.68M*
2017-09-30-$5.74M*$15.94M*$1.16M*$11.37M*
2017-06-30$173.19M*$13.34M*$666.00K*$187.20M*
2017-03-31-$19.09M-$788.00K$891.00K-$18.98M
2016-12-31$1.94M*$42.45M*$501.00K*$44.89M*
2016-09-30-$14.18M*$11.31M*$251.00K*-$2.62M*
2016-06-30$15.75M*-$21.48M*$130.00K*-$5.52M*
2016-03-31-$5.54M$13.58M$48.00K$8.07M
2015-12-31-$8.17M*-$50.85M*$135.00K*$82.51M*$23.63M*
2015-09-30-$7.77M*$1.30M*$119.00K*-$3.30M*-$9.65M*
2015-06-30-$6.11M*-$28.97M*$73.10M*$38.02M*
2015-03-31-$5.37M-$52.04M$835.00K*-$56.58M
2014-12-31-$4.40M*-$664.00K*$0.00*$16.15M*$11.09M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Monopar Therapeutics (MNPR)United States$0.598B-34.82
Altimmune, Inc. (ALT)United States$0.593B-6.43
CorMedix Inc. (CRMD)United States$0.605B3.25
Aquestive Therapeutics, Inc. (AQST)United States$0.606B-6.67
IMPACT BIOMEDICAL INC. (IBO)United States$0.611B66.47
Phathom Pharmaceuticals, Inc. (PHAT)United States$0.572B-8.76
Neurogene Inc. (NGNE)$0.625B-4.46
Shattuck Labs, Inc. (STTK)United States$0.634B-13.30
BlossomHill Therapeutics, Inc. (BLSM)United States$0.647B
Indaptus Therapeutics, Inc. (INDP)United States$0.537B